Additional Information
Specialty | |
---|---|
Manufacturer | |
Brand |
OTSC® system is a new class of endoscopic clipping which provides significantly more strength and better tissue capture compared with conventional clips delivered through the working channel of a flexible endoscope.
The primary applications include the following:
Ovesco products are intended for use in flexible endoscopic procedures in the upper and lower gastrointestinal tract. Procedures include the use of OTSC® for tissue compression for haemostasis and for the closure of wall lesion.
The mini OTSC® novel compact design provides the same trusted treatment approaches to smaller lumens and hard-to-reach lesions in the GI tract.
Ovesco products are intended for use in flexible endoscopic procedures in the upper and lower gastrointestinal tract. Procedures include the use of OTSC® for tissue compression for haemostasis and for the closure of wall lesion.
The exceptional properties and therapeutic functions of the OTSC® clip are based on its special materials and design. The super elastic Nitinol® is biocompatible and if necessary, even suited to be applied as a long term implant. In general the OTSC® Clip will be displaced from the site of application before 12 weeks.
The teeth of the OTSC® clip are spaced wide enough to allow for microperfusion of blood to the tissue, ensuring tissue healing.
The stentfix OTSC® System is the innovative solution for stent fixation in the digestive tract. It is a specially developed OTSC® System for the fixation of metal stents.
The rounded design of the stentfix OTSC® clip adapts perfectly to the gastrointestinal anatomy (especially the esophagus) without obstructing the passage of food through the lumen.
Due to it‘s modified cap shape, the stentfix OTSC® clip can easily be positioned parallel to the stent opening for optimal stent mesh and tissue capture by the clip.
The compact design of the stentfix OTSC® System also allows the passage through a stent (min. Ø 16 mm), therefore, its fixation is possible either proximally or distally.
The latest evidence shows that the use of Ovesco OTSC® as a first-line endoscopic treatment for high-risk GI bleeds results in a primary haemostasis success rate of 92.4%. The study found that the OTSC® overcomes limitations of standard clips and achieves a more efficient and reliable haemostasis in non-variceal upper gastrointestinal bleeding (NVUGIB). Read the complete abstract of the FLETRock study.
The STING trial is the only RCT designed to provide level II evidence of conventional therapy and Ovesco OTSC® efficacy in treating high-risk GI bleeds.
For high-risk GI bleeds, the STING trial shows that Ovesco OTSC® achieves a primary haemostasis rate of 93.8% compared to 56.3% for standard therapy (TTS clips, adrenaline injections, coagulation). Read the STING trial report from the DGE-BV Conference.
Specialty | |
---|---|
Manufacturer | |
Brand |
The information contained within this website is designed and intended for healthcare professionals only.
Endotherapeutics will not be liable for any actions taken in reliance of the information contained within the website. The information contained within the website does not constitute medical advice.
If you are a patient who requires treatment or management of a medical condition, please click No and you will be redirected to Endo Personal Care.